PT - JOURNAL ARTICLE AU - Anukriti, Kumari AU - Guleria, Kiran AU - Tyagi, Vipin AU - Suneja, Amita AU - Banerjee, B D TI - Maternal blood and amnionic oxytocin receptor gene expression and serum oxytocin levels in preterm birth: a case control study AID - 10.1101/2020.07.18.20155879 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.18.20155879 4099 - http://medrxiv.org/content/early/2020/07/20/2020.07.18.20155879.short 4100 - http://medrxiv.org/content/early/2020/07/20/2020.07.18.20155879.full AB - Background The oxytocin (OXT)-oxytocin receptor (OXTR) system provides promising candidate gene for studies of genetic contributions to prematurity.Objective Quantification and comparison of oxytocin receptor (OXTR) gene expression and serum OXT levels in the blood and amnion of women delivering preterm and evaluation of the correlation between OXTR gene expression in blood and amnion with serum OXT levels in them.Methods 70 pregnant women in spontaneous labor delivering vaginally preterm i.e < 37 weeks and equal number of matched controls delivering spontaneously at term (37-42 weeks) were recruited. Maternal serum OXT levels taken in active stage of labor i.e 4 cm cervical dilatation were quantified by ELISA. Gene expression studies in the maternal blood and amnion were done by using real time quantitative polymerase chain reaction (RT-qPCR).Results The mean serum OXT level in PTL was 48.56 ± 6.97 pg/ml; significantly higher than in controls (43.00 ± 3.96 pg/ml), p<0.001. OXTR gene expression both in maternal blood (2.5 times) and amnion (3.5 times) were significantly higher in PTL. A significant positive correlation was observed between serum OXT levels and OXTR gene expression in amnion (r = −0.190, p = 0.025).Conclusions The serum OXT levels and OXTR gene expression in amnion surge significantly in active phase of PTL. Thus, amnion probably links OXT-PTGs autocrine paracrine circuit to facilitate PTL. Future studies are needed to devise better OXTR receptor antagonists preferably acting on amnionic OXTRs to prevent PTL.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialit is a case control observational studyFunding Statement1. Intra-Mural Research Grant (IMRG) - UCMS, University of Delhi, India (2014-2016). 2. ICMR- The work has been carried out under MD thesis program with the support of extramural grant entitled, A study on gene environment interaction and high risk phenotypes in the etiology of preterm birth in North Indian population (ref ID: 5/7/575/11-RHN)" sanctioned by ICMR for the duration 2012-2016 to one of the author BDB as Principal Investigator.Indian Council of medical research (ICMR), India, project grant to Biochemistry department of UCMS institution for research purposes. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been approved by Institutional Ethics Committee for Human Research (IEC-HR), UCMS and GTB hospital, University of Delhi, India and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. IEC/R/2436/2014All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the relevent data pertaining to the study have been provided in the manuscript. Further data will be provided on request.